chr3-122610623-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001113523.3(PARP15):āc.436G>Cā(p.Glu146Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000343 in 1,399,252 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001113523.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PARP15 | NM_001113523.3 | c.436G>C | p.Glu146Gln | missense_variant | 3/12 | ENST00000464300.7 | NP_001106995.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PARP15 | ENST00000464300.7 | c.436G>C | p.Glu146Gln | missense_variant | 3/12 | 1 | NM_001113523.3 | ENSP00000417214.2 | ||
PARP15 | ENST00000483793.5 | c.436G>C | p.Glu146Gln | missense_variant | 3/9 | 1 | ENSP00000417785.1 | |||
PARP15 | ENST00000465304.5 | n.412G>C | non_coding_transcript_exon_variant | 4/14 | 2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000255 AC: 4AN: 156850Hom.: 0 AF XY: 0.0000120 AC XY: 1AN XY: 83024
GnomAD4 exome AF: 0.0000343 AC: 48AN: 1399252Hom.: 0 Cov.: 30 AF XY: 0.0000464 AC XY: 32AN XY: 690150
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 26, 2024 | The c.436G>C (p.E146Q) alteration is located in exon 3 (coding exon 3) of the PARP15 gene. This alteration results from a G to C substitution at nucleotide position 436, causing the glutamic acid (E) at amino acid position 146 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at